Key Stats
Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.
Stock Score/grades
The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company
- Altman Z Score 1.28
- Piotroski Score 2.00
- Grade Buy
- Symbol (REPL)
- Company Replimune Group, Inc.
- Price $11.07
- Changes Percentage (-1.43%)
- Change -$0.16
- Day Low $11.00
- Day High $11.35
- Year High $12.97
Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes simplex virus 1, which is in Phase I/II clinical trials for a range of solid tumors; and that is in Phase II clinical trials for patients with cutaneous squamous cell carcinoma. It is also developing RP2, which is in Phase I clinical trials for an anti-CTLA-4 antibody-like protein in order to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3 that is in Phase I clinical trials to express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts.
- Last Earnings
- Ex-Dividend for 5/16 Dividend
- Dividend Payable
- Today N/A
- Next Earnings (Estimated) 02/06/2025
- Fiscal Year End N/A
- Average Stock Price Target $17.00
- High Stock Price Target $43.00
- Low Stock Price Target $13.00
- Potential Upside/Downside N/A
- Consensus Rating Sell
- Rating Score (0-4) N/A
- Research Coverage N/A
- EPS (Most Recent Fiscal Year) -$3.24
- Trailing P/E Ratio -2.44
- Forward P/E Ratio -2.44
- P/E Growth -2.44
- Net Income $-215,794,000
Income Statement
Quarterly
Annual
Latest News of REPL
The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.
-
Julen Lopetegui facing two make-or-break matches as West Ham consider replacements
West Ham's manager Lopetegui is under intense scrutiny after a poor start to the season. The club is considering replacements, with former Dortmund manager Terzic in the mix. Results against Newcastle...
By The Guardian | 1 day ago -
WestJet replaces passengers' simple return flight with brutal 72-hour...
A Canadian couple faced a travel nightmare after their WestJet flight from Las Vegas was canceled, leading to a 72-hour journey with multiple stops. They eventually spent over $2,000 on an Air Canada ...
By New York Post | 1 day ago -
Charlotte football coaching job profile: Pluses, minuses and candidates to replace Biff Poggi
The Charlotte football job is open after firing Biff Poggi. Despite potential in the AAC, the program lacks consistent success. Candidates like Pep Hamilton, Joe Cox, and Kerwin Bell are considered fo...
By The New York Times | 1 day ago
